Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) لـ Age-Related Cognitive Decline

A

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None مقابل: None Outcome: Neurological health outcomes التأثير: None None

المجتمع المدروس: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d مقابل: None Outcome: Cognitive decline in AD التأثير: None None

المجتمع المدروس: Alzheimer's disease patients

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None مقابل: None Outcome: Age-dependent brain lipid changes التأثير: None None

المجتمع المدروس: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Key Statistics

58

الدراسات

12000

المشاركون

Positive

A

التقييم

Referenced Papers

Molecules (Basel, Switzerland) 2025 10 اقتباسات
Journal of proteome … 2025 8 اقتباسات
Journal of Alzheimer's … 2025 3 اقتباسات
Nutrients 2025 2 اقتباسات
Handbook of experimental … 2025 1 اقتباسات
Current opinion in … 2023 58 اقتباسات
Alzheimer's & dementia … 2023 7 اقتباسات
Nutrients 2022 76 اقتباسات
International journal of … 2022 23 اقتباسات
Biomolecules 2021 161 اقتباسات
Current nutrition reports 2019 310 اقتباسات
Nutricion hospitalaria 2019 40 اقتباسات
American family physician 2018 101 اقتباسات
Pharmacological research 2018 67 اقتباسات
Nutricion hospitalaria 2018 32 اقتباسات
Frontiers in psychology 2018 13 اقتباسات
Advances in nutrition … 2017 215 اقتباسات
Annals of the … 2016 89 اقتباسات
Nutricion hospitalaria 2014 17 اقتباسات
Advances in nutrition … 2013 155 اقتباسات
Current treatment options … 2011 6 اقتباسات
Molecular neurobiology 2010 145 اقتباسات
Women's health (London, … 2010 48 اقتباسات
JAMA 2010 3 اقتباسات
The Practitioner 2010
The Cochrane database … 2009 299 اقتباسات
Prostaglandins, leukotrienes, and … 2009 258 اقتباسات
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 اقتباسات
Prostaglandins, leukotrienes, and … 2006 176 اقتباسات
Medecine sciences : … 2005 19 اقتباسات
The Cochrane database … 2003 263 اقتباسات
Journal of Alzheimer's … 2003 161 اقتباسات
Pharmacological research 1999 1060 اقتباسات
Alternative medicine review … 1999 112 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

الحد الأعلى: 3,000 mg/day combined DHA/EPA (FDA GRAS)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --

أفضل وقت للتناول: With meals containing fat for better absorption

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

التفاعلات المعروفة

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

الحد الأقصى المسموح به: 3,000 mg/day combined DHA/EPA (FDA GRAS)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support Age-Related Cognitive Decline management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.